BfR Warns Against Unnecessary Micronutrient Supplementation in Healthy Elderly
Germany's BfR advises that healthy older individuals typically do not require micronutrient supplements, as their needs are met through a balanced diet, prompting manufacturers to reassess product positioning. Concerns also raised over infant Vitamin D overdose.
Bonn, Germany — 24 August 2026
The German Federal Institute for Risk Assessment (BfR) has issued guidance asserting that healthy elderly individuals can meet their nutritional requirements through a balanced diet, rendering micronutrient supplementation largely unnecessary. This position, dated 24 August 2026, challenges the broad market trend of formulating and promoting general micronutrient supplements for the ageing population. The BfR emphasises that supplements are typically only beneficial in specific cases of deficiency or medical necessity, underscoring the importance of medical consultation before commencement.
Separately, the BfR highlighted risks associated with excessive Vitamin D intake, particularly in infants. A communication from 07 August 2026 detailed that excessively high Vitamin D consumption can lead to hypervitaminosis D, or Vitamin D poisoning. This reiterates the critical need for precise dosing and clear instructions for highly potent supplements, especially those targeting vulnerable populations such as infants.
The BfR, as an independent scientific institution under the Federal Ministry of Food and Agriculture (BMEL), provides risk assessment and communication on food, feed, chemicals, and product safety. Its pronouncements hold significant weight for both consumer perception and regulatory enforcement within Germany and can influence wider EU discussions. The Institute’s findings are rooted in toxicological, microbiological, and nutritional-physiological assessments, making them a benchmark for product safety and efficacy claims.
These recent statements suggest a tightening stance on indiscriminate supplement use and highlight the importance of targeted, evidence-based supplementation. Manufacturers are advised to critically review their portfolio's scientific substantiation for all age-specific claims, especially those implying general health benefits without clear deficiency states.
What this means for Germany
German manufacturers and brand owners must adapt marketing strategies for senior-targeted supplements, shifting from general wellness to condition-specific or deficiency-based positioning. Regulatory bodies, including regional food inspectorates, will likely increase scrutiny of unsupported 'healthy ageing' claims, potentially leading to product withdrawals or mandatory labelling changes. Manufacturers face reformulation windows to incorporate medical professional advice into product recommendations or face competitive pressure from brands aligning with BfR's cautious approach. Ensuring stringent quality control and precise dosage for infant Vitamin D products is paramount to avoid serious adverse events and subsequent regulatory action.
For more on UK formulation and manufacturing best practice, learn more at Supplement Factory.